Request a Proposal
Geistek helps biotech, pharma and medical device innovators move faster, smarter and with greater confidence - combining deep regulatory expertise with hands on operational support across the full development journey.
One coordinated partner across strategy, operations, data and regulatory execution.
We stay with you through every submission, agency interaction and post approval step. preserving continuity from preclinical planning to market access.
Most delays are not caused by a lack of science. They happen when regulatory strategy, clinical execution and agency expectations are not aligned early enough.
A single EMA submission error can set a programme back 12 to 18 months.
We define the regulatory path early, anticipating agency expectations before costly commitments are made.
Most early stage biotechs lack in house regulatory depth across every development stage.
We become an extension of your team, bringing specialist knowledge without the overhead of building it all internally.
Misaligned planning creates avoidable dead ends and expensive redesigns.
We connect study design, endpoints, agency advice and clinical operations into one coherent development plan.
Fragmented support means losing context exactly when it matters most.
We stay with your programme through submissions, agency interactions, approval and market access.
Agency-aligned regulatory pathways from preclinical through approval, anticipating EMA expectations at every stage.
Continuous submission and agency interaction support. No handoffs, no gaps. one team until approval is secured.
End-to-end operational management of clinical programmes, fully integrated with the regulatory strategy.
Support from approval to market, ensuring regulatory work translates into a successful commercial launch.
Coordinated strategy across both agencies, including parallel scientific advice and endpoint alignment.
Clinical protocols designed to meet FDA and EMA evidentiary expectations while avoiding duplicative studies.
Geistek works as an embedded regulatory partner, combining agency specific expertise, operational continuity and strategic thinking from early development to market access.
We become part of your team, preserving context across every milestone instead of appearing only at isolated moments.
From non GLP preclinical planning to market access, one partner connects the journey.
We design the roadmap and help execute it, reducing the gap between plan and delivery.
Agency specific knowledge that reduces submission risk and accelerates confident decisions.
Tell us where your programme stands today. We will review your context and identify how Geistek can support your regulatory, clinical or market access pathway.
Share the essentials. Our team will review your programme and come back with a focused next step.
